Top segments and regional performance

Last year, the company generated ‪46.43 B‬ EUR, the most of which — ‪15.01 B‬ EUR — came from its top-performing segment, Oncology, compared to ‪13.81 B‬ EUR the previous year. The greatest contribution came from United States, which accounted for ‪20.81 B‬ EUR last year, with ‪19.81 B‬ EUR the year before.